Lexaria Bioscience Corp. reported raising $1.2 Million in an initial SEC Form D filing, from an offering of $1.2 Million
Amount Raised
$1.2 Million
Round Type
Venture
KelownaOtherBiotechnologyHealthcareWho else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Lexaria Bioscience that raised within 45 days of this round, from Fundz verified event records.
- Kalera Medical, Inc. raised $23M on February 2, 2022.
- Passage Bio raised $4M (Seed) on February 1, 2022.
- Fractyl Health raised $20M on January 25, 2022.
- Reimagine Care raised $25M (Series A) on January 25, 2022.
- Talphera, Inc. raised $5.2M on January 24, 2022.
- Enliven Therapeutics raised an undisclosed amount (Funding Round) on January 19, 2022.
Who to call at Lexaria Bioscience, and when
A new round usually means Lexaria Bioscience is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Lexaria Bioscience raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lexaria Bioscience, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lexaria Bioscience. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lexaria Bioscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Lexaria Bioscience raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.